Delivery Order SPE2DB22D3501-SPE2DB24FUL45
- Not listed
- This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,431.48 and an ultimate completion date of December 12, 2022. It is a firm fixed price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
- This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, and has a ceiling value of $10,866.06. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It has an ultimate completion date of June 11, 2024. The contract does not...
- This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, through its Corporate Office division. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $20,643.94. It has an ultimate completion date of July 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp, worth $1,743.42, is for the delivery of Prolia 60 mg/mL syringes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen's federal contracting activities. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to...
- This federal contract award is for the delivery of PROLIA 60 MG/ML SYRINGE medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $13,440.30. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 7, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of a pharmaceutical product, Prolia 60 mg/mL syringe. The contract has a ceiling value of $3,486.84 and a completion date of May 1, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support...
- This contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $8,209.35 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order with a firm fixed price and has an ultimate completion date of October 25, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of pharmaceutical products, specifically Prolia 60 mg/mL syringes, to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $3,486.84 and is a delivery order with a firm fixed-price pricing type. It was awarded on April 15, 2024, with a...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Prolia 60 mg/mL syringes, a specialty pharmaceutical product, with a ceiling value of $10,460.52 and a performance period through April 12, 2024. This is a firm fixed price delivery order contract, with no set-aside designation noted. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUL45Delivery Order
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,652.47 and a ceiling value of $2,652.47. The ultimate completion date is February 6, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/5/24 |